Author

Anni Lepland

Tartu University HospitalORCID 0000-0002-6448-4847Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Cancer Biology· 1 Genetic & Genomic Medicine· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:benchmarking· 1 Approach:experimental assay· 1 Assay:GWAS summary statistics· 1 Research Focus:host-pathogen & immune response· 1 Organism:human· 1 Organism:mouse· 1 Approach:statistical model· 1 Research Focus:variant effect prediction· 1

Frequent Co-Authors

Anette Paas· 1 shared Anna Padrik· 1 shared Anne Ilves· 1 shared Ave-Triin Tihamäe· 1 shared Eliana K. AsciuttoiD· 1 shared Elisa PeranzoniiD· 1 shared Filipa SampaioiD· 1 shared Gerardo AcostaiD· 1 shared

Activity by Year

2025-2025 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 21 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperGenetic & Genomic Medicine

Anette Paas

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

An implementation study of the service model for genetic risk-based stratified breast cancer screening - Estonian results of the BRIGHT project

Madli Tamm, Peeter Padrik, Kristiina Ojamaa, Anette Paas, Anni Lepland, Krista Kruuv-Käo, Liis Leitsalu, Siim Sõber, Laura Roht, Sander Pajusalu, Tiina Kahre, Anna Padrik, Jagnar Pindmaa, Kadri Luga, Ly Rootslane, , Neeme Tõnisson

The paper evaluates a genetic risk-based breast cancer screening model in younger women, showing its feasibility, clinical utility, and acceptability.

Clinical Breast Cancer · Sep 11, 2025Peer-reviewedGenetic & Genomic Medicine

Therapeutic Tumor Macrophage Reprogramming in Breast Cancer Through a Peptide-Drug Conjugate

Anni Lepland, Elisa Peranzoni, Uku Haljasorg, Eliana K. Asciutto, Maria Crespí‐Amer, Lorenzo Modesti, Kalle Kilk, Manuel Lombardía, Gerardo Acosta, Míriam Royo, Pärt Peterson, Ilaria Marigo, Tambet Teesalu, Pablo Scodeller

This paper develops a peptide-drug conjugate, MACTIDE-V, that reprograms tumor-associated macrophages in breast cancer, reducing metastasis and enhancing anti-tumor immunity.

Advanced Science · Jan 22, 2025Peer-reviewedCancer Biology